Your browser doesn't support javascript.
Hemolytic crisis in a patient treated with eculizumab for paroxysmal nocturnal hemoglobinuria possibly triggered by SARS-CoV-2 (COVID-19): a case report.
Schüller, Hannah; Klein, Franziska; Lübbert, Michael; Prager, Eric Peter.
  • Schüller H; Department of Nephrology, University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Klein F; Department of Nephrology, University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Lübbert M; Department of Hematology, Oncology & Stem Cell Transplantation, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Prager EP; Department of Nephrology, University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany. eric.peter.prager@uniklinik-freiburg.de.
Ann Hematol ; 100(3): 841-842, 2021 Mar.
Article in English | MEDLINE | ID: covidwho-917114

Full text: Available Collection: International databases Database: MEDLINE Main subject: Complement Inactivating Agents / Antibodies, Monoclonal, Humanized / SARS-CoV-2 / COVID-19 / Hemoglobinuria, Paroxysmal / Anemia, Hemolytic Type of study: Case report Topics: Long Covid Limits: Aged / Female / Humans Language: English Journal: Ann Hematol Journal subject: Hematology Year: 2021 Document Type: Article Affiliation country: S00277-020-04318-6

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Complement Inactivating Agents / Antibodies, Monoclonal, Humanized / SARS-CoV-2 / COVID-19 / Hemoglobinuria, Paroxysmal / Anemia, Hemolytic Type of study: Case report Topics: Long Covid Limits: Aged / Female / Humans Language: English Journal: Ann Hematol Journal subject: Hematology Year: 2021 Document Type: Article Affiliation country: S00277-020-04318-6